Myo-inositol in Down syndrome amniotic fluid. A case-control study

Prenatal Diagnosis

Volumn 34, Issue 9, 2014, Pages 917-918

  Santamaria, Angelo ^a   Corrado, Francesco ^a   Interdonato, Maria Lieta ^a   Baviera, Giovanni ^a   Carlomagno, Gianfranco ^b   Cavalli, Pietro ^b   Unfer, Vittorio ^b   D'Anna, Rosario ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b A G Un Co Obstetrics and gynecology center ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL PHOSPHOLIPASE D; INOSITOL; BIOLOGICAL MARKER;

ADULT; AMNIOCENTESIS; AMNION FLUID; BODY MASS; BRAIN LEVEL; CASE CONTROL STUDY; CHROMOSOME 21; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; LETTER; MASS FRAGMENTOGRAPHY; MATERNAL AGE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RETROSPECTIVE STUDY; UPREGULATION; METABOLISM; PREGNANCY; SECOND TRIMESTER PREGNANCY; GENETIC SCREENING; INDUCED ABORTION;

ADULT; AMNIOTIC FLUID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOWN SYNDROME; FEMALE; HUMANS; INOSITOL; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES; UP-REGULATION;

EID: 84908334693     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4398     Document Type: Letter

References (11)

1. Shetty HU, Schapiro MB, Holloway HW, Rapoport SI. Polyol profiles in Down syndrome. Myo-Inositol, specifically, is elevated in the cerebrospinal fluid. J Clin Invest 1995;95:542-6.
2. Hauser G, Finelli VN. The biosynthesis of free and phosphatide myo-inositol from glucose by mammalian tissue slices. J Biol Chem 1963;238:3224-8.
3. Sleight S, Wilson BA, Heimark DB, Larner J. G (q/11) is involved in insulin-stimulated inositol phosphoglycan putative mediator generation in rat liver membranes: co-localization of G(q/11) with the insulin receptor in membrane vesicles. Biochem Biophys Res Commun 2002;295:561-9.
4. Schofield JN, Stephens JW, Hurel SJ, et al. Insulin reduces serum glycosylphosphatidylinositolphospholipase D levels in human type I diabetic patients and streptozotocin diabetic rats. Mol Genet Metab 2002;75:154-61.
5. Deborde S, Schofield JN, Rademacher TW. Placental GPI-PLD is of maternal origin and its GPI substrate is absent from placentae of pregnancies associated with pre-eclampsia. J Reprod Immunol 2003;59:277-94.
6. Anderson RG. The caveolae membrane system. Annu Rev Biochem 1998;67:199-225
7. Fruen BR, Lester BR. Down's syndrome fibroblasts exhibit enhanced inositol uptake. Biochem J 1990;270:119-23.
8. Lamar M, Foy CM, Beacher F, et al. Down syndrome with and without dementia: an in vivo proton magnetic resonance spectroscopy study with implications for Alzheimer's disease. Neuroimage 2011;57:63-8.
9. Huang W, Alexander GE, Daly EM, et al. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. Am J Psychiatry 1999;156:1879-86.
10. Semenova NA, Akhadov TA, Petryaykin AV, et al. Metabolic dysfunction and relationship in human frontoparietal cortex in severe traumatic brain injury: single-voxel (1) H magnetic resonance spectroscopy study. Biochemistry 2012;77:388-94.
11. Biessels GJ, Koffeman A, Scheltens P. Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic. J Neurol 2006;253:477-82.